Skip to content

Comparative Effects of Shockwave Therapy and Eccentric Exercises in Patients With Lateral Epicondylitis

Comparative Effects of Shockwave Therapy and Eccentric Exercises on Pain, Functional Ability, Quality of Life, Grip Strength and Range of Motion in Patients With Lateral Epicondylitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07523893
Enrollment
50
Registered
2026-04-13
Start date
2026-02-02
Completion date
2026-06-30
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tennis Elbow

Keywords

Lateral epicondylitis, Shockwave Therapy, Eccentric Exercises, Grip Strength

Brief summary

The goal of this randomized controlled trial is to compare the effects of shockwave therapy and eccentric exercises on pain, functional ability, quality of life, grip strength and range of motion in patients with lateral epicondylitis. Participants will be randomly assigned to either Group A (Shockwave therapy) or Group B (Eccentric Exercises) using a computer-generated random number tables method. The intervention will be provided over five weeks, with three sessions per week (total of 15 sessions): Group A (Shockwave therapy): Participants will receive shockwave therapy, for 5 min with energy level 7.0 m J and frequency 6 Hz. Group B (Eccentric Exercises): Participants will receive eccentric exercises, repeating each 10 repetitions 3 sets per session with a 1 min rest between each of them. Outcomes will be assessed at baseline, week 0 and week 5 to evaluate which exercise program is more effective in reducing symptoms and improving functional outcomes.

Interventions

OTHERShockwave Therapy

Participants will receive shockwave therapy, for 5 min with energy level 7.0 m J and frequency 6 Hz.

Participants will receive eccentric exercises, repeating each 10 repetitions 3 sets per session with a 1 min rest between each of them

Sponsors

Ibadat International University, Islamabad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants will be informed that both interventions are effective physiotherapy treatments for lateral epicondylitis but will not be told which group they belonged to. The outcome assessor will remain blinded to group allocation throughout data collection at baseline and week 5. To maintain blinding, participants will be instructed not to disclose their exercise details during assessment, and all data will be recorded using coded identifiers (Group A or B).

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with Lateral epicondylitis * Patients with 20-50 years * Both males and females * Willing to participate and provide informed consent

Exclusion criteria

* Patients with recent trauma (fractures, injury etc.) * Patients with blood clotting disorder (including thrombosis), oral anti-coagulants, and pacemaker, tumors at site of treatment, infected area or skin rupture or abrasion at the site of treatment, pregnancy. * Cervical Radiculopathy or any diseases that mimic or refer pain to elbow. * Patients who received steroid injection within 6 weeks.

Design outcomes

Primary

MeasureTime frameDescription
Pain IntensityAssessment will be done at baseline and on Week 5Pain intensity will be measured by Visual Analogue Scale
Functional AbilityAssessment will be done at baseline and on Week 5Functional ability will be measured by Patient-Related Tennis Elbow Evaluation
Quality of Life of PatientsAssessment will be done at baseline and on Week 5Quality of Life will be measured by SF-36 short form
Grip StrengthAssessment will be done at baseline and on Week 5Grip Strength will be measured by Dynamometer
Range of MotionAssessment will be done at baseline and on Week 5Range of Motion will be measured by Goniometer.

Countries

Pakistan

Contacts

CONTACTYousra Bahadar, MS-PT(MSK)*
yousrabahadar111@gmail.com00923130522747
CONTACTFatima Amjad, MS-SPT
fatima.amjad@uipt.iiui.edu.pk00923330940975
PRINCIPAL_INVESTIGATORMuhammad Nazim Farooq, PhD-PT

Ibadat International University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026